Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter

Molecular and Cellular Biology

Volumn 22, Issue 13, 2002, Pages 4522-4534

  Benkoussa, Madjid ^a   Brand, Céline ^a   Delmotte, Marie Hélène ^a   Formstecher, Pierre ^a   Lefebvre, Philippe ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GLYCOGEN SYNTHASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C JUN; PROTEIN FOS; RETINOIC ACID RECEPTOR; RNA POLYMERASE II; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 2;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REPRESSION; GENE CONTROL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR INTRINSIC ACTIVITY; TRANSACTIVATION; TRANSCRIPTION INITIATION;

ANISOMYCIN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CREB-BINDING PROTEIN; DIMERIZATION; DNA; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; HELA CELLS; HUMANS; MAP KINASE KINASE 1; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, RETINOIC ACID; REPRESSOR PROTEINS; RESPONSE ELEMENTS; RETINOID X RECEPTORS; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRETINOIN; ULTRAVIOLET RAYS;

ATRA;

EID: 0036272982     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.13.4522-4534.2002     Document Type: Article

References (54)

1. Stressinduced MAP kinase hog1 is part of transcription activation complexes
2. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
3. Phorbol-ester inducible genes contain a common cis-element recognized by a TPA-modulated trans-acting factor
4. Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro
5. Limited proteolysis for assaying ligand binding affinities of nuclear receptors
6. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains
7. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
8. The C-terminal domain-phosphorylated IIO form of RNA polymerase II is associated with the transcription repressor NC2 (Dr1/DRAP1) and is required for transcription activation in human nuclear extracts
9. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation
10. 1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation
11. Glucocorticoids repress NF-kappa B-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell
12. Negative regulation of Jun/AP-1: Conserved function of glycogen synthase kinase 3 and the Drosophila kinase shaggy
13. Serine 157, a retinoic acid receptor alpha residue phosphorylated by protein kinase C in vitro, is involved in RXR.RARalpha heterodimerization and transcriptional activity
14. Control of retinoic acid receptor heterodimerization by ligand-induced structural transitions
15. Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos
16. Regulation of human involucrin promoter activity by a protein kinase C, Ras, MEKK1, MEK3, p38/RK, AP1 signal transduction pathway
17. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation
18. Anisomycin selectively desensitizes signalling components involved in stress kinase activation and fos and jun induction
19. Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos
20. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
21. The regulation of AP-1 activity by mitogen-activated protein kinases
22. Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonists
23. A molecular mechanism for the effect of lithium on development
24. All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity
25. H11-H12 loop retinoic acid receptor mutants exhibit distinct trans-activating and trans-repressing activities in the presence of natural or synthetic retinoids
26. Structural determinants of the ligand-binding site of the human retinoic acid receptor alpha
27. Protein phosphatases 1 and 2A regulate the transcriptional and DNA binding activities of retinoic acid receptors
28. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation
29. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acidinduced apoptosis in human breast cancer cells
30. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor-correlation with retinoid induction of U937 cell differentiation
31. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain
32. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976
33. The C-terminal domain of c-fos is required for activation of an AP-1 site specific for jun-fos heterodimers
34. A C-terminal domain in FosB, absent in FosB/SF and Fra-1, which is able to interact with the TATA binding protein, is required for altered cell growth
35. Allosteric regulation of the discriminative responsiveness of retinoic acid receptor to natural and synthetic ligands by retinoid X receptor and DNA
36. Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha
37. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site
38. Glycogen synthase kinase-3 phosphorylates jun family members in vitro and negatively regulates their transactivating potential in intact cells
39. Repression of c-fos gene expression by thyroid hormone and retinoic acid receptors
40. Differential effect of Rac and Cdc42 on p38 kinase activity and cell cycle progression of nonadherent primary mouse fibroblasts
41. Identification of amino acids critical for the DNA binding and dimerization properties of the human retinoic acid receptor alpha. Importance of lysine 360, lysine 365, and valine 361
42. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system
43. Extra-cellular signal-regulated kinase 1/2-mediated phosphorylation of JunD and FosB is required for okadaic acid-induced activator protein 1 activation
44. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun
45. Retinoic acid is a negative regulator of AP-1-responsive genes
46. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
47. A protein kinase C-dependent activity modulates retinoic acid-induced transcription
48. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
49. 3-mediated transcriptional repression of the granulocyte-macrophage colony-stimulating factor gene: Vitamin D receptor competes for DNA binding with NFAT1 and stabilizes c-Jun
50. Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids
51. Transformation by Fos proteins requires a C-terminal transactivation domain
52. Coactivator and corepressor complexes in nuclear receptor function
53. Studies of nematode TFIIE function reveal a link between Ser-5 phosphorylation of RNA polymerase II and the transition from transcription initiation to elongation
54. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion